TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change From Baseline Hemoglobin at End-of-Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of appropriate ICD therapy or sudden cardiac death
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity of the HPI algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the HPI algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PIPP score ≥ 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in BUN (mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Obesity related anthropometric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious adverse events (SAE) grade 3 or above
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Absorbed dose for selected organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSHβX1 splice variant expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sentinel Node Identification Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Early sepsis markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of target lesions with patency at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with freedom from BTK major adverse limb events (MALE) and/or perioperative death (POD)
Endpoint domain: Adverse events/effects
Primary endpoint: Pneumococcal vaccination coverage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Functional outcome on Constant score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Subject retention and trial completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance with taking study agent
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Modified Rankin Scale (mRS) scores at Day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With At Least One Triptan-Related Adverse Experience (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With At Least One Clinical AE
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With At Least One Laboratory AE
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With At Least One Vital Sign Measurement Outside Predefined Limits of Change
Endpoint domain: Adverse events/effects
Primary endpoint: Diet Quality per shopping trip
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Endogenous thrombin potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Drop Out Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: percent change from baseline in ACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of spatial correlation between local fluorescence and conventional imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain during the latest 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in psychosocial functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of Patients with Acute Kidney Injury (AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of participants with hospital acquired pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) of sirolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose limiting toxicities of sirolimus
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Moorong Self-Efficacy Scale (MSES)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical tumor regression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: resting tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: postural tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: hypokinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rigidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Cardiovascular Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety and tolerability of foretinib at the MTD
Endpoint domain: Adverse events/effects
Primary endpoint: Total plasma concentration of free DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total plasma concentration of nucleosomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Harvey Bradshaw Index HBI: Decrease >3 Points or Remission Score<5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulcerative Colitis Clinical Score UCCS Decrease >3 Points or Remission Score <3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change Inflammatory Bowel Disease Questionnaire SIBDQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Organ- and non-organ specific autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in Fitzpatrick Wrinkle Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Length of stay of the epidural catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: unit-level incidence rate of patient and visitor physical aggression
Endpoint domain: Adverse events/effects
Primary endpoint: unit-level incidence rate of patient and visitor verbal aggression
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of NMDA receptor antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in Exercise Treadmill Testing (ETT) Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative complication rates in 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Clavien-Dindo grade of postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of daily health symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute graft-versus-host disease incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Generalized Anxiety Disorder 7-item scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cell-mediated immunity and antibody response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With HPA Axis Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Brain Injury Self-Efficacy Scale (BICS-Q)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Concentration-Time Curve of Bezlotoxumab From Time 0 to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Discontinued Study Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: ASAS 20 responder at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APAIS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: STAI-6 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Colloid volume kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement/remission
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in General Social Outcome Measure (GSOM)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Social Responsiveness Scale (SRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of post-surgical infectious complications
Endpoint domain: Adverse events/effects
Primary endpoint: Hamilton Depression Rating Scale (HDRS) - 24 Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiovascular and all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Aggregated Pathology Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bronchoalveolar Lavage (BAL): Eosinophil Count (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Induced Sputum: Eosinophil Count (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Speech Understanding (% Correct) in Quiet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Understanding (% Correct) in Noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Css, max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plasma Concentration of R-spondin 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plasma Concentration of R-spondin 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plasma Concentration of R-spondin 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plasma Concentration of R-spondin 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of deliveries vaginally
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Early post operative mortality
Endpoint domain: Mortality/survival
Primary endpoint: Admission Rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Pain at 6 and 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The percentage of the normal gastric slow waves in electrogastrograph
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Flow-mediated Dilation (FMD) Percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Numerical pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance on variety of cognitive tasks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: sleep, measured with actigraphy
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: subjective alertness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sub-therapeutic levels of measured antiinfectiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Triglyceride Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MAGE (mean amplitude of glycemic excursion) index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants with normal serum potassium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite procedure-related complication
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of Patients With Success Defined by no or Mild Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DOAC plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum Measured Concentration (Cmax) of the Analytes in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve (AUC 0-tz) of the Analytes in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ablation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to reach clinical milestones for safe discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long term abstinence from smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clotting activity based on ROTEM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clotting activity based on FVIII:C concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleed frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Varenicline Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in intravenous antibiotic days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Weight in Kilograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in blood levels of hydrogen sulfide and nitrite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in IBS or MUPS symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttraumatic Stress Disorder symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of cerebral performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of nutritional parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of neurodegenerative biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood Transfusion requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: DTI MRI findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of caregiver-child interactions
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: electromyography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: motor skills in the upper limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Safety Endpoint of Serious Asthma Outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With at Least One Asthma Exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Urine Flow Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants Exhibiting Abnormal EMG Activity During Voiding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Average Scores on ICIQ-LUTSqol
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average Scores on QOL Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in verbal memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in emotion regulation performance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of PTSD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Probability of Unreversed 2-point Decline in Motor-language (ML) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of Unreversed Motor-language (ML) Score of Zero
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Pressure Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Surface Area (TSA) > 30 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly urine tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Weight at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Head circumference at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radioactive counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of maxillary 1st molar distalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Blood Stream Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Rated Wrist Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Severity of treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD): Frequency of Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline BMI at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline Physical activity at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Nutrition at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Likelihood of being concussed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects Achieving an Objective Skin Response of at Least 4 Months Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean Change in UPDRS Part III Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of FOBTs to diagnose CRC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of FOBTs to diagnose advanced colorectal neoplasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of FOBTs to diagnose advanced adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calf blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulated postoperative morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of the FAST-O rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial wall inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in PCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial injury markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total radioactivity in urine and faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent terminal elimination half-life [t1/2]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean reduction in MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: freedom from grade 3 and 4 MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serious Adverse Event (SAE) rates
Endpoint domain: Adverse events/effects
Primary endpoint: Retention in drug abuse treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Acute GU and GI toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Postprandial glycemic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satiety feeling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Final score on the visual analogous scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in Power Doppler (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation coefficient of TEWL curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Anxiety Levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Life Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Burnout level as measured by the Maslach-Burnout-Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood Oxygen Level Dependent (BOLD) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dupuytren's disease severity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Venous Thromboembolism (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of DGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Harvey Bradshaw Index (HBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bowel wall thickness on sonographic findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes